Is minimal clinically important difference relevant for the interpretation of clinical trials in pediatric rheumatic diseases?

Journal of Rheumatology

Volumn 34, Issue 3, 2007, Pages 463-465

  Ruperto, Nicolino ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; METHOTREXATE;

CHILD; CHILDHOOD DISEASE; CLINICAL RESEARCH; CONCEPT FORMATION; EDITORIAL; HEALTH CARE QUALITY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RHEUMATIC DISEASE; SOCIAL PSYCHOLOGY; TREATMENT RESPONSE;

CHILD; CLINICAL TRIALS; HUMANS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RHEUMATIC DISEASES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33847672278     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (20)

1. Strand CV, Russell AS. WHO/LAR taskforce on quality of life. J Rheumatol 1997;24:1630-3.
2. Landgraf JM, Abetz L, Ware JE. The CHQ user's manual. 1st ed. Boston: The Health Institute, New England Medical Center; 1996.
3. Varni JW, Seid M, Rode CA. The PedsQLTM: measurement model for the pediatric quality of life inventory. Med Care 1999; 37:126-39.
4. Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994;37;1761-9.
5. Martini A, Ruperto N, for the Paediatric Rheumatology International Trials Organization (PRINTO). Quality of life in juvenile idiopathic arthritis patients compared to healthy children. Clin Exp Rheumatol 2001;19 Suppl 23:S1-S172.
6. Feldman BM, Grundland B, McCullough L, Wright V. Distinction of quality of life, health related quality of life, and health status in children referred for rheumatologic care. J Rheumatol 2000; 27:226-33.
7. Gong GWK, Young NL, Dempster H, Porepa M, Feldman BM. The Quality of My Life questionnaire: the minimal clinically important difference for pediatric rheumatology patients. J Rheumatol 2007;34:581-7.
8. Liang MH. Evaluating measurement responsiveness. J Rheumatol 1995;22:1191-2.
9. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-15.
10. Beaton DE, Bombardier C, Katz JN, et al. Looking for important change/differences in studies of responsiveness. J Rheumatol 2001;28:400-5.
11. Wells G, Beaton D, Shea B, et al. Minimal clinically important differences: Review of methods. J Rheumatol 2001;28:406-12.
12. Dempster H, Porepa M, Young N, Feldman BM. The clinical meaning of functional outcome scores in children with juvenile arthritis. Arthritis Rheum 2001;44:1768-74.
13. Brunner HI, Klein-Gitelman MS, Miller MJ, et al. Minimal clinically important differences of the Childhood Health Assessment Questionnaire. J Rheumatol 2005;32:150-61.
14. Gutierrez-Suarez R, Pistorio A, Cespedes CA, et al. Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO Multinational Quality of Life Cohort Study. Rheumatology Oxford 2006; Jul 28, E-pub ahead of print.
15. Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 2000;342:763-9.
16. Ruperto N, Murray KJ, Gerloni V, et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 2004;50:2191-201.
17. Ruperto N, Ravelli A, Murray KJ, et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology Oxford 2003;42:1452-9.
18. Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
19. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
20. Ruperto N, Ravelli A, Cuttica R, et al. The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the disease activity core set. Arthritis Rheum 2005;52:2854-64.